企業プロフィール
KALA BIO 株価・ニュース・カタリスト
- ティッカー:
- KALA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.82 USD (-2.38%)
終値
最終更新: 2026年8月21日
44.4M USD
時価総額
株価変動の要因
As of Aug 21, 2026, KALA closed down 2.38% at $0.8201. No new same-company headline was identified in the current news window.
企業概要
事業概要
KALA BIO is an eye-care biotechnology company focused on corneal and ocular surface disease. Its story centers on developing therapies for chronic ophthalmic conditions with limited treatment options.
所在地とセクター分類
KALA BIO is headquartered in the United States and listed on NASDAQ. It sits in ophthalmology biotechnology.
ビジネスモデルの特徴
The company depends on clinical progress, regulatory milestones, and the ability to commercialize a focused eye-care pipeline. Investors watch data, safety, and access strategy.
バイオ業界での位置付け
KALA occupies a niche ophthalmology position within biotech. It is catalyst-sensitive because eye-disease programs often hinge on a narrow set of data events.
今後のカタリスト
- KALA Bio is largely a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. There is no live standalone growth story left.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。